BioMarin Pharmaceutical Inc. (0HNC.L)

USD 66.73

(-0.75%)

Total Debt Summary of BioMarin Pharmaceutical Inc.

  • BioMarin Pharmaceutical Inc.'s latest annual total debt in 2023 was 1.13 Billion USD , up 4.7% from previous year.
  • BioMarin Pharmaceutical Inc.'s latest quarterly total debt in 2024 Q3 was 594.62 Billion USD , down -45.19% from previous quarter.
  • BioMarin Pharmaceutical Inc. reported annual total debt of 1.08 Billion USD in 2022, up 0.37% from previous year.
  • BioMarin Pharmaceutical Inc. reported annual total debt of 1.07 Billion USD in 2021, up 0.37% from previous year.
  • BioMarin Pharmaceutical Inc. reported quarterly total debt of 1.09 Billion USD for 2024 Q2, up 1.07% from previous quarter.
  • BioMarin Pharmaceutical Inc. reported quarterly total debt of 594.62 Billion USD for 2024 Q3, down -45.19% from previous quarter.

Annual Total Debt Chart of BioMarin Pharmaceutical Inc. (2023 - 1998)

Historical Annual Total Debt of BioMarin Pharmaceutical Inc. (2023 - 1998)

Year Total Debt Total Debt Growth
2023 1.13 Billion USD 4.7%
2022 1.08 Billion USD 0.37%
2021 1.07 Billion USD 0.37%
2020 1.07 Billion USD 26.77%
2019 848.12 Million USD 2.13%
2018 830.41 Million USD -29.29%
2017 1.17 Billion USD 71.9%
2016 683.23 Million USD 3.16%
2015 662.28 Million USD 0.66%
2014 657.97 Million USD 0.37%
2013 655.56 Million USD 88.26%
2012 348.22 Million USD -0.03%
2011 348.32 Million USD -7.73%
2010 377.52 Million USD -24.05%
2009 497.08 Million USD 602.68%
2008 70.74 Million USD -85.96%
2007 503.68 Million USD 118.3%
2006 230.72 Million USD 2.88%
2005 224.25 Million USD -17.2%
2004 270.84 Million USD 116.67%
2003 125 Million USD 1443.21%
2002 8.1 Million USD 45.89%
2001 5.55 Million USD 6589.16%
2000 83 Thousand USD -25.23%
1999 111 Thousand USD 11.0%
1998 100 Thousand USD 0.0%

Peer Total Debt Comparison of BioMarin Pharmaceutical Inc.

Name Total Debt Total Debt Difference
Editas Medicine, Inc. 36.53 Million USD -3003.446%
Dynavax Technologies Corporation 256.91 Million USD -341.344%
Supernus Pharmaceuticals, Inc. 41.52 Million USD -2630.452%
Perrigo Company plc 4.07 Billion USD 72.164%
Illumina, Inc. 2.26 Billion USD 49.873%
Thermo Fisher Scientific Inc. 34.91 Billion USD 96.753%
Iovance Biotherapeutics, Inc. 1 Million USD -113287.5%
Walgreens Boots Alliance, Inc. 9.55 Billion USD 88.132%
IQVIA Holdings Inc. 14.23 Billion USD 92.032%
Heron Therapeutics, Inc. 173.75 Million USD -552.579%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 58.05%
Unity Biotechnology, Inc. 26.99 Million USD -4101.093%
Waters Corporation 2.35 Billion USD 51.863%
Biogen Inc. 7.33 Billion USD 84.548%
Sangamo Therapeutics, Inc. 38.1 Million USD -2875.737%
Evolus, Inc. 126.54 Million USD -796.018%
Adicet Bio, Inc. 17.7 Million USD -6304.988%
Cara Therapeutics, Inc. 43.16 Million USD -2526.717%
bluebird bio, Inc. 330.32 Million USD -243.259%
Esperion Therapeutics, Inc. 540.94 Million USD -109.609%
FibroGen, Inc. 170.45 Million USD -565.205%
Agilent Technologies, Inc. 2.73 Billion USD 58.542%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD -5329.335%
Homology Medicines, Inc. 44.05 Million USD -2473.83%
Geron Corporation 85.89 Million USD -1220.01%
Alnylam Pharmaceuticals, Inc. 2.39 Billion USD 52.716%
Amicus Therapeutics, Inc. 445.05 Million USD -154.77%
Myriad Genetics, Inc. 145 Million USD -681.983%
Viking Therapeutics, Inc. 1.26 Million USD -89890.079%
Intellia Therapeutics, Inc. 115.34 Million USD -883.021%
Zoetis Inc. 6.8 Billion USD 83.333%
Abeona Therapeutics Inc. 4.4 Million USD -25658.178%
Mettler-Toledo International Inc. 2.16 Billion USD 47.694%
Vertex Pharmaceuticals Incorporated 808.4 Million USD -40.262%
Kala Pharmaceuticals, Inc. 36.32 Million USD -3021.645%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD 21.992%
Atara Biotherapeutics, Inc. 57.87 Million USD -1859.281%
Verastem, Inc. 41.55 Million USD -2628.481%
Nektar Therapeutics 230.4 Million USD -392.131%
Axsome Therapeutics, Inc. 186.37 Million USD -508.393%
Aclaris Therapeutics, Inc. 3.07 Million USD -36785.979%
Sarepta Therapeutics, Inc. 1.39 Billion USD 18.824%
OPKO Health, Inc. 326.56 Million USD -247.214%
Exelixis, Inc. 189.94 Million USD -496.952%
Neurocrine Biosciences, Inc. 428.4 Million USD -164.677%
Corcept Therapeutics Incorporated 151 Thousand USD -750810.596%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 138.4 Million USD -719.221%
Imunon, Inc. 1.13 Million USD -99424.442%
Blueprint Medicines Corporation 774.12 Million USD -46.472%
Insmed Incorporated 1.2 Billion USD 5.824%
Halozyme Therapeutics, Inc. 1.49 Billion USD 24.37%
Agios Pharmaceuticals, Inc. 56.98 Million USD -1889.673%
TG Therapeutics, Inc. 110.79 Million USD -923.399%
Incyte Corporation 38.28 Million USD -2861.514%
Emergent BioSolutions Inc. 877.5 Million USD -29.217%